Literature DB >> 25153807

[Congenital chylothorax: rapid and complete response to polyvidone iodine].

F Hmami1, A Oulmaati2, C Bouchikhi3, A Banani3, A Bouharrou2.   

Abstract

Idiopathic congenital chylothorax refers to abnormal accumulation of lymphatic fluid within the pleural space due the disruption of the thoracic duct or its lymphatic tributaries. It is a relatively rare disease and a cause of neonatal respiratory distress with major nutritional and immunological consequences. Therefore, it is critical to decrease pleural effusion promptly. Conservative treatment is always started as soon as the diagnosis is made, and refractory cases require chemical pleurodesis or surgery. However, the choice and timing of therapeutic escalation is not clear in the neonatal period and long waiting periods may have adverse consequences for the baby. We report a case of congenital idiopathic chylothorax who did not respond to conservative treatment after 18 days in whom one intrapleural injection of 5 mL of 4% concentrated Betadine stopped the pleural effusion promptly, effectively, and definitively, with no side effects observed, thus challenging such delayed administration.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25153807     DOI: 10.1016/j.arcped.2014.06.006

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  2 in total

1.  [Role of lymphatic scintigraphy and surgery in congenital chylothorax].

Authors:  Jihène Methlouthi; Nabiha Mahdhaoui; Manel Bellalah; Nouir Selsabil; Ayache Hedia; Raja Sfar; Habib Essabah; Nouri Abdellatif; Nouri Sonia; Seboui Hassen
Journal:  Pan Afr Med J       Date:  2016-08-22

2.  Chemical pleurodesis and somatostatin in treating spontaneous chylothorax in pediatric patients: a retrospective analysis and review of the literature.

Authors:  Wei-Guang Long; Bin Cai; Jian-Ming Deng; Yang Liu; Wen-Jie Wang; Juan Luo
Journal:  Transl Pediatr       Date:  2020-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.